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Introduction
Systemic Lupus Erythematosus (SLE) is disease which
may have severe and variable activity in the pediatric
population.
Objectives
compare the index of activity in two times at cohort of
pediatric patients with SLE.
Methods
Analytic descriptive study. 89 patients with diagnosis SLE
(1986 ACR criteria) from a rheumatology center at a
pediatric hospital were evaluated at the time of diagnosis
and twelve months after. Medical records were reviewed
registering the following variables: score SLEDAI,
Antinuclear antibodies (ANAs), Anti-DNA antibodies
and complement C3 and C4 levels. Analysis was done
through parametric and non parametric tests to compare
means and proportions using STATA11. Shapiro-Wilk
and Wilcoxon tests (non-normally distributed data) were
applied.
Results
Median score SLEDAI at the time of diagnosis was 23
(min 4 max 61); after 12 months it was 4 (min 0 max
31) (p = 0.001). Antinuclear antibodies (ANAs) reactivity
at the diagnosis was 88,1%; after 12 months it was 6,67%
(p = 0.17). Anti-DNA antibodies reactivity at the diag-
nosis was 66,7%; after 12 months it was 56,41% (p =
0.01). C3 level was diminished in 67,95% of patients at
the diagnosis; after 12 months it was diminished in
33,3% of patients (p = 0.01). C4 level was diminished in
71,7% of patients at the diagnosis; after 12 months it
was diminished in 40% of patients (p = 0.01).
Conclusion
Statistical significance was documented regarding score
SLEDAI, Anti-DNA antibodies reactivity, hypocomple-
mentemia for the time of diagnosis and twelve month
follow-up. This suggests that improvement in disease
activity was due to the established treatment.
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